Janus Henderson Group PLC Bristol Myers Squibb CO Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Janus Henderson Group PLC holds 972,019 shares of BMY stock, worth $44.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
972,019
              Previous 1,182,599
              
        
           17.81%
        
      
          
        Holding current value
$44.3 Million
            Previous $72.1 Million
            
        
           37.62%
        
      
          
        % of portfolio
0.02%
            Previous 0.04%
          
        Shares
	  33 transactions
	
  Others Institutions Holding BMY
# of Institutions
2,664Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.3M- 
    
      Vanguard Group Inc Valley Forge, PA195MShares$8.89 Billion0.15% of portfolio
- 
    
      Black Rock Inc. New York, NY159MShares$7.24 Billion0.15% of portfolio
- 
    
      Jpmorgan Chase & CO New York, NY108MShares$4.93 Billion0.52% of portfolio
- 
    
      State Street Corp Boston, MA94.7MShares$4.32 Billion0.17% of portfolio
- 
    
      Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.23 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...